Cargando…

Evaluating the Short-Term Costs and Benefits of a Nationwide Diabetes Prevention Programme in England: Retrospective Observational Study

BACKGROUND: Prevention programmes typically incur short-term costs and uncertain long-term benefits. We use the National Health Service (NHS) England Diabetes Prevention Programme (NHS-DPP) to investigate whether behaviour change programmes may be cost-effective even within the short-term participat...

Descripción completa

Detalles Bibliográficos
Autores principales: McManus, Emma, Meacock, Rachel, Parkinson, Beth, Sutton, Matt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628047/
https://www.ncbi.nlm.nih.gov/pubmed/37787972
http://dx.doi.org/10.1007/s40258-023-00830-8
_version_ 1785131669036990464
author McManus, Emma
Meacock, Rachel
Parkinson, Beth
Sutton, Matt
author_facet McManus, Emma
Meacock, Rachel
Parkinson, Beth
Sutton, Matt
author_sort McManus, Emma
collection PubMed
description BACKGROUND: Prevention programmes typically incur short-term costs and uncertain long-term benefits. We use the National Health Service (NHS) England Diabetes Prevention Programme (NHS-DPP) to investigate whether behaviour change programmes may be cost-effective even within the short-term participation period. METHODS: We analysed 384,611 referrals between June 2016 and March 2019. We estimated NHS costs using implementation costs and provider payments. We used linear regressions to relate utility changes to the number of sessions attended, based on responses to the five-level EQ-5D (EQ-5D-5L) at baseline and final session for 18,959 participants. We then calculated the corresponding quality-adjusted life year (QALY) change for all 384,611 referrals by combining the estimated regression coefficients with the observed level of attendance, with individuals that did not attend any programme sessions being assumed to experience zero benefit. In secondary analysis, we added weight change, recorded for 18,105 participants to the regression and applied predicted values to all referrals with missing weight change values estimated using multiple imputation with chained equations. We then estimated the cost-per-QALY generated. RESULTS: Average cost per referral was £119 (standard deviation: £118; 2020 price year, UK £ Sterling). Each session attended was associated with a 0.0042 increase in utility (95% confidence interval (CI): 0.0025–0.0059). This generated 1,773 QALYs across all referrals (95% CI: 889–2,656). Cost-per-QALY was £24,929 (95% CI: £16,635–49,720) when implementation costs were excluded. Secondary analysis showed each session attended and kilogram of weight lost were associated with 0.0034 (95% CI: 0.0016–0.0051) and 0.0025 (95% CI: 0.0020–0.0031) increases in utility, respectively. These generated 1,542 QALYs, at a cost-per-QALY of £28,661 when implementation costs were excluded. CONCLUSION: Participants experienced small utility gains from session attendance and weight loss during their programme participation. These benefits alone made this low-cost behaviour change programme potentially cost-effective in the short-term. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40258-023-00830-8.
format Online
Article
Text
id pubmed-10628047
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-106280472023-11-08 Evaluating the Short-Term Costs and Benefits of a Nationwide Diabetes Prevention Programme in England: Retrospective Observational Study McManus, Emma Meacock, Rachel Parkinson, Beth Sutton, Matt Appl Health Econ Health Policy Original Research Article BACKGROUND: Prevention programmes typically incur short-term costs and uncertain long-term benefits. We use the National Health Service (NHS) England Diabetes Prevention Programme (NHS-DPP) to investigate whether behaviour change programmes may be cost-effective even within the short-term participation period. METHODS: We analysed 384,611 referrals between June 2016 and March 2019. We estimated NHS costs using implementation costs and provider payments. We used linear regressions to relate utility changes to the number of sessions attended, based on responses to the five-level EQ-5D (EQ-5D-5L) at baseline and final session for 18,959 participants. We then calculated the corresponding quality-adjusted life year (QALY) change for all 384,611 referrals by combining the estimated regression coefficients with the observed level of attendance, with individuals that did not attend any programme sessions being assumed to experience zero benefit. In secondary analysis, we added weight change, recorded for 18,105 participants to the regression and applied predicted values to all referrals with missing weight change values estimated using multiple imputation with chained equations. We then estimated the cost-per-QALY generated. RESULTS: Average cost per referral was £119 (standard deviation: £118; 2020 price year, UK £ Sterling). Each session attended was associated with a 0.0042 increase in utility (95% confidence interval (CI): 0.0025–0.0059). This generated 1,773 QALYs across all referrals (95% CI: 889–2,656). Cost-per-QALY was £24,929 (95% CI: £16,635–49,720) when implementation costs were excluded. Secondary analysis showed each session attended and kilogram of weight lost were associated with 0.0034 (95% CI: 0.0016–0.0051) and 0.0025 (95% CI: 0.0020–0.0031) increases in utility, respectively. These generated 1,542 QALYs, at a cost-per-QALY of £28,661 when implementation costs were excluded. CONCLUSION: Participants experienced small utility gains from session attendance and weight loss during their programme participation. These benefits alone made this low-cost behaviour change programme potentially cost-effective in the short-term. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40258-023-00830-8. Springer International Publishing 2023-10-03 2023 /pmc/articles/PMC10628047/ /pubmed/37787972 http://dx.doi.org/10.1007/s40258-023-00830-8 Text en © Crown 2023 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research Article
McManus, Emma
Meacock, Rachel
Parkinson, Beth
Sutton, Matt
Evaluating the Short-Term Costs and Benefits of a Nationwide Diabetes Prevention Programme in England: Retrospective Observational Study
title Evaluating the Short-Term Costs and Benefits of a Nationwide Diabetes Prevention Programme in England: Retrospective Observational Study
title_full Evaluating the Short-Term Costs and Benefits of a Nationwide Diabetes Prevention Programme in England: Retrospective Observational Study
title_fullStr Evaluating the Short-Term Costs and Benefits of a Nationwide Diabetes Prevention Programme in England: Retrospective Observational Study
title_full_unstemmed Evaluating the Short-Term Costs and Benefits of a Nationwide Diabetes Prevention Programme in England: Retrospective Observational Study
title_short Evaluating the Short-Term Costs and Benefits of a Nationwide Diabetes Prevention Programme in England: Retrospective Observational Study
title_sort evaluating the short-term costs and benefits of a nationwide diabetes prevention programme in england: retrospective observational study
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628047/
https://www.ncbi.nlm.nih.gov/pubmed/37787972
http://dx.doi.org/10.1007/s40258-023-00830-8
work_keys_str_mv AT mcmanusemma evaluatingtheshorttermcostsandbenefitsofanationwidediabetespreventionprogrammeinenglandretrospectiveobservationalstudy
AT meacockrachel evaluatingtheshorttermcostsandbenefitsofanationwidediabetespreventionprogrammeinenglandretrospectiveobservationalstudy
AT parkinsonbeth evaluatingtheshorttermcostsandbenefitsofanationwidediabetespreventionprogrammeinenglandretrospectiveobservationalstudy
AT suttonmatt evaluatingtheshorttermcostsandbenefitsofanationwidediabetespreventionprogrammeinenglandretrospectiveobservationalstudy